The market value of Novo Nordisk, the Danish company that makes the weight loss drugs Wegovy and Ozempic, hit $500 billion in late January-a rare achievement for a European firm. Novo Nordisk is owned by a nonprofit foundation, which gives the company an unusual corporate structure. Adam and Cameron discuss.
Follow and listen to more episodes of Ones and Tooze: podcasts.apple.com/us/podcast...
Subscribe to all of Foreign Policy’s Podcasts at foreignpolicy.com/podcasts/ or wherever you get your podcasts
Visit foreignpolicy.com/ to read the latest global news and analysis from FP.
Follow Foreign Policy:
Twitter - / foreignpolicy
Instagram - / foreignpolicymag
Facebook - / foreign.policy.magazine
LinkedIn - / foreign-policy-magazine
TikTok - / foreignpolicymagazine
8 фев 2024
